---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-043760"
form_type: "8-K"
ticker: "BCPC"
cik: "0000009326"
company_name: "BALCHEM CORP"
filed_at: "2024-10-25T23:59:59+00:00"
generated_at: "2026-05-30T10:17:49.151994+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Balchem Q3 net sales up 4.3% to $239.9M; record adjusted EBITDA $64.4M, up 7.6% YoY

## Summary
- GAAP EPS $1.03 versus $0.90 prior year; adjusted EPS record $1.13 versus $1.04.
- Human Nutrition & Health and Specialty Products segments drove strong sales and earnings growth.
- Cash from operations $51.3M; free cash flow $42.2M; repaid $39.6M revolving debt, net debt $153.3M (0.6x leverage).
- Launched K2Vital Delta Fermented, VitaCholine Pro-Flo, and AminoShure-XL during the quarter.
- Year-to-date 2024 net earnings $94.9M vs $81.9M; net sales $713.7M vs $693.7M.

## SEC filing metadata
- accession: 0001628280-24-043760
- form_type: 8-K
- ticker: BCPC
- cik: 0000009326
- company_name: BALCHEM CORP
- filed_at: 2024-10-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/9326/000162828024043760/0001628280-24-043760-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/9326/000162828024043760/bcpc-20241025.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-043760
- JSON: https://secwatch.observer/filing/0001628280-24-043760.json
- Plain text: https://secwatch.observer/filing/0001628280-24-043760.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.